"Pneumococcal Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
Below are MeSH descriptors whose meaning is more general than "Pneumococcal Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Pneumococcal Vaccines".
This graph shows the total number of publications written about "Pneumococcal Vaccines" by people in Harvard Catalyst Profiles by year, and whether "Pneumococcal Vaccines" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 2 | 5 |
| 2005 | 7 | 2 | 9 |
| 2006 | 4 | 2 | 6 |
| 2007 | 6 | 3 | 9 |
| 2008 | 4 | 0 | 4 |
| 2009 | 8 | 7 | 15 |
| 2010 | 12 | 0 | 12 |
| 2011 | 12 | 7 | 19 |
| 2012 | 9 | 5 | 14 |
| 2013 | 14 | 5 | 19 |
| 2014 | 4 | 1 | 5 |
| 2015 | 19 | 1 | 20 |
| 2016 | 8 | 2 | 10 |
| 2017 | 17 | 6 | 23 |
| 2018 | 12 | 3 | 15 |
| 2019 | 10 | 4 | 14 |
| 2020 | 10 | 4 | 14 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 14 | 15 |
Below are the most recent publications written about "Pneumococcal Vaccines" by people in Profiles.
-
Effectiveness of 13-valent pneumococcal conjugate vaccine on radiological primary end-point pneumonia among cases of severe community acquired pneumonia in children: A prospective multi-site hospital-based test-negative study in Northern India. PLoS One. 2022; 17(12):e0276911.
-
Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study. Eur J Clin Microbiol Infect Dis. 2022 Nov; 41(11):1365-1370.
-
Effect of Maternal Immunization With 10-Valent Pneumococcus Conjugate Vaccine (PCV-10), 23-Valent Pneumococcus Polysaccharide Vaccine, or Placebo on the Immunogenicity of PCV-10 in Human Immunodeficiency Virus-Exposed Uninfected Infants: A Randomized Clinical Trial. Clin Infect Dis. 2022 09 29; 75(6):996-1005.
-
Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt. Hum Vaccin Immunother. 2022 Nov 30; 18(6):2114252.
-
Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. Sci Transl Med. 2022 08 03; 14(656):eabm4065.
-
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years. Vaccine. 2022 07 29; 40(31):4190-4198.
-
Targeted Transcriptomic Screen of Pneumococcal Genes Expressed during Murine and Human Infection. Infect Immun. 2022 07 21; 90(7):e0017522.
-
Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance. Clin Infect Dis. 2022 05 03; 74(9):1639-1649.
-
Comparative Genomics of Disease and Carriage Serotype 1 Pneumococci. Genome Biol Evol. 2022 04 10; 14(4).
-
Population structure of ocular Streptococcus pneumoniae is highly diverse and formed by lineages that escape current vaccines. Microb Genom. 2022 03; 8(3).